1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Gonzalez, C.
Langdon, G.
Bruix, M.
Galvez, A.
Valdivia, E.
Maqueda, M.
Rico, M.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Proc.Natl.Acad.Sci.USA
PNASA6
0040
0027-8424
97
11221
10.1073/PNAS.210301097
11005847
Bacteriocin as-48, a Microbial Cyclic Polypeptide Structurally and Functionally Related to Mammalian Nk-Lysin
2000
NE
J.Biomol.NMR
JBNME9
0800
0925-2738
12
173
10.1023/A:1008267725043
9729795
Sequence-Specific 1H Assignment and Secondary Structure of the Bacteriocin as-48 Cyclic Peptide
1998
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
PEPTIDE LINK BETWEEN RESIDUES 1 AND 70
7177.538
AS-48 PROTEIN
BACTERIOCIN AS-48, RESIDUES 36-105
1
nat
polymer
BACTERIOCIN AS-4, PEPTIDE ANTIBIOTIC AS-48
no
no
MAKEFGIPAAVAGTVLNVVEAGGWVTTIVSILTAVGSGGLSLLAAAGRESIKAYLKKEIKKKGKRAVIAW
MAKEFGIPAAVAGTVLNVVEAGGWVTTIVSILTAVGSGGLSLLAAAGRESIKAYLKKEIKKKGKRAVIAW
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
sample
1351
ENTEROCOCCUS FAECALIS
PMB2
repository
Initial release
Database references
Derived calculations
Other
Refinement description
Structure summary
Version format compliance
1
0
2000-10-25
1
1
2011-08-03
HELIX
DETERMINATION METHOD: AUTHOR PROVIDED.
PDBE
Y
PDBE
2000-08-09
REL
PEPTIDE LINK BETWEEN RESIDUES 1 AND 70
NONE
20
20
NOESY
COSY
TOCSY
3
pH
1
atm
298
K
REFINEMENT DETAILS CAN BE FOUND IN THE JRNL CITATION ABOVE.
RESTRAINED MOLECULAR DYNAMICS
P. GUNTERT ET AL. (DYANA-1.5), VAN GUNSTEREN ET AL. (GROMOS)
refinement
DYANA-1.5, GROMOS
GROMOS
structure solution
DYANA
structure solution
GROMOS
600
Bruker
AMX
MET
1
n
1
MET
1
A
ALA
2
n
2
ALA
2
A
LYS
3
n
3
LYS
3
A
GLU
4
n
4
GLU
4
A
PHE
5
n
5
PHE
5
A
GLY
6
n
6
GLY
6
A
ILE
7
n
7
ILE
7
A
PRO
8
n
8
PRO
8
A
ALA
9
n
9
ALA
9
A
ALA
10
n
10
ALA
10
A
VAL
11
n
11
VAL
11
A
ALA
12
n
12
ALA
12
A
GLY
13
n
13
GLY
13
A
THR
14
n
14
THR
14
A
VAL
15
n
15
VAL
15
A
LEU
16
n
16
LEU
16
A
ASN
17
n
17
ASN
17
A
VAL
18
n
18
VAL
18
A
VAL
19
n
19
VAL
19
A
GLU
20
n
20
GLU
20
A
ALA
21
n
21
ALA
21
A
GLY
22
n
22
GLY
22
A
GLY
23
n
23
GLY
23
A
TRP
24
n
24
TRP
24
A
VAL
25
n
25
VAL
25
A
THR
26
n
26
THR
26
A
THR
27
n
27
THR
27
A
ILE
28
n
28
ILE
28
A
VAL
29
n
29
VAL
29
A
SER
30
n
30
SER
30
A
ILE
31
n
31
ILE
31
A
LEU
32
n
32
LEU
32
A
THR
33
n
33
THR
33
A
ALA
34
n
34
ALA
34
A
VAL
35
n
35
VAL
35
A
GLY
36
n
36
GLY
36
A
SER
37
n
37
SER
37
A
GLY
38
n
38
GLY
38
A
GLY
39
n
39
GLY
39
A
LEU
40
n
40
LEU
40
A
SER
41
n
41
SER
41
A
LEU
42
n
42
LEU
42
A
LEU
43
n
43
LEU
43
A
ALA
44
n
44
ALA
44
A
ALA
45
n
45
ALA
45
A
ALA
46
n
46
ALA
46
A
GLY
47
n
47
GLY
47
A
ARG
48
n
48
ARG
48
A
GLU
49
n
49
GLU
49
A
SER
50
n
50
SER
50
A
ILE
51
n
51
ILE
51
A
LYS
52
n
52
LYS
52
A
ALA
53
n
53
ALA
53
A
TYR
54
n
54
TYR
54
A
LEU
55
n
55
LEU
55
A
LYS
56
n
56
LYS
56
A
LYS
57
n
57
LYS
57
A
GLU
58
n
58
GLU
58
A
ILE
59
n
59
ILE
59
A
LYS
60
n
60
LYS
60
A
LYS
61
n
61
LYS
61
A
LYS
62
n
62
LYS
62
A
GLY
63
n
63
GLY
63
A
LYS
64
n
64
LYS
64
A
ARG
65
n
65
ARG
65
A
ALA
66
n
66
ALA
66
A
VAL
67
n
67
VAL
67
A
ILE
68
n
68
ILE
68
A
ALA
69
n
69
ALA
69
A
TRP
70
n
70
TRP
70
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
A
N
C
MET
TRP
1
70
1.33
2
A
A
HA2
HZ2
GLY
LYS
22
56
1.32
2
A
A
N
C
MET
TRP
1
70
1.34
3
A
A
N
C
MET
TRP
1
70
1.32
4
A
A
N
C
MET
TRP
1
70
1.34
5
A
A
HH21
HG13
ARG
ILE
65
68
1.06
5
A
A
N
C
MET
TRP
1
70
1.33
6
A
A
N
C
MET
TRP
1
70
1.33
7
A
A
N
C
MET
TRP
1
70
1.32
8
A
A
HG13
HG21
VAL
ILE
11
31
1.30
8
A
A
N
C
MET
TRP
1
70
1.33
9
A
A
N
C
MET
TRP
1
70
1.33
10
A
A
N
C
MET
TRP
1
70
1.33
11
A
A
HG13
HG21
VAL
ILE
11
31
1.25
11
A
A
N
C
MET
TRP
1
70
1.33
11
A
A
O
HG
THR
SER
27
30
1.55
12
A
A
N
C
MET
TRP
1
70
1.32
13
A
A
N
C
MET
TRP
1
70
1.33
14
A
A
N
C
MET
TRP
1
70
1.33
15
A
A
N
C
MET
TRP
1
70
1.34
15
A
A
HG11
HG21
VAL
ILE
11
31
1.34
15
A
A
O
HG
THR
SER
27
30
1.58
16
A
A
N
C
MET
TRP
1
70
1.33
16
A
A
O
HG
THR
SER
27
30
1.59
17
A
A
N
C
MET
TRP
1
70
1.33
18
A
A
N
C
MET
TRP
1
70
1.32
19
A
A
N
C
MET
TRP
1
70
1.33
19
A
A
O
HG
THR
SER
27
30
1.58
20
A
A
N
C
MET
TRP
1
70
1.32
3
A
ALA
2
-10.87
3
A
GLU
58
-10.53
4
A
ALA
2
-10.32
6
A
GLY
47
-10.19
7
A
GLU
4
10.11
7
A
GLY
47
-10.02
9
A
ALA
2
-10.09
10
A
ALA
2
-10.75
12
A
ALA
2
-10.39
12
A
LYS
56
-11.52
13
A
ALA
2
-10.27
14
A
GLY
47
-10.18
14
A
GLU
58
-11.57
16
A
ALA
2
-11.22
16
A
VAL
18
-10.10
17
A
GLY
47
-10.10
17
A
LYS
56
-10.17
18
A
GLU
58
-10.03
20
A
ALA
2
-10.89
2
A
ASN
17
0.073
SIDE CHAIN
5
A
TYR
54
0.086
SIDE CHAIN
8
A
TYR
54
0.066
SIDE CHAIN
9
A
TYR
54
0.090
SIDE CHAIN
11
A
TYR
54
0.099
SIDE CHAIN
12
A
ARG
48
0.081
SIDE CHAIN
12
A
TYR
54
0.070
SIDE CHAIN
13
A
ARG
65
0.120
SIDE CHAIN
16
A
TYR
54
0.062
SIDE CHAIN
18
A
TYR
54
0.079
SIDE CHAIN
20
A
ASN
17
0.246
SIDE CHAIN
5
3.60
0.50
120.30
123.90
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
65
65
65
N
7
9.13
1.50
110.90
120.03
A
A
A
CA
CB
CG1
VAL
VAL
VAL
18
18
18
N
8
-17.36
2.60
111.60
94.24
A
A
A
CB
CG
CD
LYS
LYS
LYS
61
61
61
N
10
3.15
0.50
120.30
123.45
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
48
48
48
N
10
-3.55
0.50
120.30
116.75
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
65
65
65
N
12
3.12
0.50
120.30
123.42
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
65
65
65
N
13
-12.00
1.80
110.60
98.60
A
A
A
N
CA
CB
ARG
ARG
ARG
65
65
65
N
13
-6.89
0.50
120.30
113.41
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
65
65
65
N
16
-14.99
1.80
110.60
95.61
A
A
A
N
CA
CB
ASN
ASN
ASN
17
17
17
N
16
-71.86
2.30
121.90
50.04
A
A
A
OD1
CG
ND2
ASN
ASN
ASN
17
17
17
N
16
-37.51
2.40
116.70
79.19
A
A
A
CB
CG
ND2
ASN
ASN
ASN
17
17
17
N
16
3.82
0.50
120.30
124.12
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
65
65
65
N
16
-3.70
0.50
120.30
116.60
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
65
65
65
N
19
-14.56
1.80
110.60
96.04
A
A
A
N
CA
CB
ARG
ARG
ARG
65
65
65
N
20
-17.93
2.20
113.40
95.47
A
A
A
CA
CB
CG
ASN
ASN
ASN
17
17
17
N
20
-72.10
2.30
121.90
49.80
A
A
A
OD1
CG
ND2
ASN
ASN
ASN
17
17
17
N
20
-19.97
2.30
111.70
91.73
A
A
A
CD
CE
NZ
LYS
LYS
LYS
52
52
52
N
20
-14.12
2.30
111.70
97.58
A
A
A
CD
CE
NZ
LYS
LYS
LYS
57
57
57
N
20
-13.44
2.20
113.40
99.96
A
A
A
CA
CB
CG
LYS
LYS
LYS
61
61
61
N
20
-16.39
2.30
111.70
95.31
A
A
A
CD
CE
NZ
LYS
LYS
LYS
61
61
61
N
20
-3.21
0.50
120.30
117.09
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
65
65
65
N
1
A
ALA
46
-144.48
50.16
1
A
SER
50
53.14
124.95
2
A
TRP
24
-57.67
100.60
2
A
SER
50
50.77
127.49
3
A
SER
50
45.86
125.77
3
A
LYS
52
-55.77
-70.05
4
A
SER
37
76.05
-38.55
4
A
SER
50
44.86
115.14
4
A
ILE
51
-23.88
-56.82
5
A
SER
50
49.75
123.55
5
A
ILE
51
-29.01
-49.80
6
A
SER
50
48.33
120.96
7
A
TRP
24
-67.43
99.80
7
A
SER
50
49.37
116.99
8
A
SER
37
73.39
-37.77
8
A
SER
50
50.21
133.18
8
A
LYS
52
-53.84
-71.20
8
A
LYS
64
-28.48
-48.38
9
A
SER
50
50.31
123.68
10
A
SER
50
44.31
127.09
10
A
LYS
64
-23.41
-46.53
11
A
SER
37
-66.58
15.59
11
A
SER
50
43.36
128.40
12
A
SER
50
48.33
121.45
13
A
SER
50
42.15
121.26
13
A
ILE
51
-27.42
-57.75
14
A
SER
50
51.50
123.62
15
A
SER
37
77.27
-40.38
15
A
SER
50
46.63
118.85
16
A
PRO
8
-82.04
38.45
16
A
ALA
9
53.85
-34.04
16
A
GLU
49
-141.15
38.70
16
A
SER
50
53.47
119.34
17
A
TRP
24
-49.60
103.15
17
A
GLU
49
-145.52
37.98
17
A
SER
50
52.96
133.37
18
A
LYS
3
-91.25
-68.54
18
A
SER
37
70.37
-39.47
18
A
SER
50
30.33
114.32
18
A
ILE
51
-26.99
-54.04
19
A
TRP
24
-62.10
98.08
19
A
SER
37
-62.04
5.74
19
A
SER
50
45.85
126.80
19
A
LYS
52
-57.41
-72.05
20
A
SER
50
50.40
121.69
20
A
LYS
64
-22.42
-47.60
AS-48 PROTEIN
Solution structure of bacteriocin AS-48
1
N
N
A
MET
1
A
MET
1
HELX_P
A
PHE
5
A
PHE
5
1
H1
5
A
ALA
9
A
ALA
9
HELX_P
A
ALA
21
A
ALA
21
1
H2
13
A
VAL
25
A
VAL
25
HELX_P
A
ALA
34
A
ALA
34
1
H3
10
A
SER
37
A
SER
37
HELX_P
A
ALA
45
A
ALA
45
1
H4
9
A
ILE
51
A
ILE
51
HELX_P
A
LYS
62
A
LYS
62
1
H5
12
A
LYS
64
A
LYS
64
HELX_P
A
TRP
70
A
TRP
70
1
H6
7
ANTIBIOTIC
ANTIBIOTIC, BACTERIOCINS, CATIONIC ANTIBACTERIAL PEPTIDES, FIVE-HELIX GLOBULE, CYCLIC POLYPEPTIDE
Q47765
UNP
1
Q47765
36
105
1E68
1
70
Q47765
A
1
1
70
1
P 1